A phase I study of MEDI4736, NNT-PD-L1 antibody in patients with advanced solid tumors

Por Zielinski, Christoph C.
Publicado no Transl Lung Cancer Res (2014)

ESMO Open—Cancer Horizons and the future of oncology

Por Zielinski, Christoph C
Publicado no ESMO Open (2016)

AIOM chooses ESMO Open—Cancer Horizons as its official journal: a warm welcome from ESMO Open

Por Zielinski, Christoph C, Pinto, Carmine
Publicado no ESMO Open (2016)

Recent developments and translational aspects in targeted therapy for metastatic breast cancer

Por Marhold, Maximilian, Bartsch, Rupert, Zielinski, Christoph
Publicado no ESMO Open (2016)

CSCO joins ESMO Open—Cancer Horizons

Por Zielinski, Christoph C, Wu, Yi-Long
Publicado no ESMO Open (2016)

Cancer immune cycle: a video introduction to the interaction between cancer and the immune system

Por Preusser, Matthias, Berghoff, Anna S, Thallinger, Christiane, Zielinski, Christoph C
Publicado no ESMO Open (2016)

Drugs for HER-2-positive breast cancer

Por Sibilia, Maria., Zielinski, Christoph C., Bartsch, Rupert., Grunt, Thomas W.
Publicado em 2011

Angiogenesis in cancer: Anti-VEGF escape mechanisms

Por Prager, Gerald W., Poettler, Marina, Unseld, Matthias, Zielinski, Christoph C.
Publicado no Transl Lung Cancer Res (2012)

Optimal Sequencing of Anti-HER2 Therapy

Por Lück, Hans-Joachim, Untch, Michael, Jackisch, Christian, Zielinski, Christoph, Bartsch, Rupert
Publicado em 2014

Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases

Por Gruenberger, Birgit, Scheithauer, Werner, Punzengruber, Robert, Zielinski, Christoph, Tamandl, Dietmar, Gruenberger, Thomas
Publicado em 2008

Public Perception of Cancer Care in Poland and Austria

Por Jȩdrzejewski, Mariusz, Thallinger, Christiane, Mrozik, Magda, Kornek, Gabriela, Zielinski, Christoph, Jassem, Jacek
Publicado no Oncologist (2015)

Bortezomib combined with rituximab and dexamethasone is an active regimen for patients with relapsed and chemotherapy-refractory mantle cell lymphoma

Por Lamm, Wolfgang, Kaufmann, Hannes, Raderer, Markus, Hoffmann, Martha, Chott, Andreas, Zielinski, Christoph, Drach, Johannes
Publicado em 2011

CD98hc (SLC3A2) drives integrin-dependent renal cancer cell behavior

Por Poettler, Marina, Unseld, Matthias, Braemswig, Kira, Haitel, Andrea, Zielinski, Christoph C, Prager, Gerald W
Publicado em 2013

Non–Small Cell Lung Cancer: Role of the Immune System and Potential for Immunotherapy

Por Carbone, David P., Gandara, David R., Antonia, Scott J., Zielinski, Christoph, Paz-Ares, Luis
Publicado no J Thorac Oncol (2015)

Risk factors for Clostridium difficile infection in hemato-oncological patients: A case control study in 144 patients

Por Fuereder, Thorsten, Koni, Danjel, Gleiss, Andreas, Kundi, Michael, Makristathis, Athanasios, Zielinski, Christoph, Steininger, Christoph
Publicado no Sci Rep (2016)

Enhanced and long term immunogenicity of a Her-2/neu multi-epitope vaccine conjugated to the carrier CRM197 in conjunction with the adjuvant Montanide

Por Tobias, Joshua, Jasinska, Joanna, Baier, Karin, Kundi, Michael, Ede, Nicholas, Zielinski, Christoph, Wiedermann, Ursula
Publicado no BMC Cancer (2017)

A phase II study of lenalidomide in patients with extranodal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT lymphoma)

Por Kiesewetter, Barbara, Troch, Marlene, Dolak, Werner, Müllauer, Leonhard, Lukas, Julius, Zielinski, Christoph C., Raderer, Markus
Publicado em 2013

Association Between Decreased Serum Albumin With Risk of Venous Thromboembolism and Mortality in Cancer Patients

Por Königsbrügge, Oliver, Posch, Florian, Riedl, Julia, Reitter, Eva-Maria, Zielinski, Christoph, Pabinger, Ingrid, Ay, Cihan
Publicado no Oncologist (2016)

Case report: impressive response to pembrolizumab in a patient with mismatch-repair deficient metastasized colorectal cancer and bulky disease

Por Kieler, Markus, Scheithauer, Werner, Zielinski, Christoph C, Chott, Andreas, Al-Mukhtar, Ali, Prager, Gerald W
Publicado no ESMO Open (2016)

Venous thromboembolism and survival in patients with high-grade glioma

Por Simanek, Ralph, Vormittag, Rainer, Hassler, Marco, Roessler, Karl, Schwarz, Martin, Zielinski, Christoph, Pabinger, Ingrid, Marosi, Christine
Publicado em 2007